Analytical Data
-
基因名
FAM109A
- Application
-
别名
PHETA1; FAM109A; Sesquipedalian-1; Ses1; 27 kDa inositol polyphosphate phosphatase-interacting protein A; IPIP27A; PH domain-containing endocytic trafficking adaptor 1
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q8N4B1
-
表达区间
1-249aa
-
氨基酸序列
MKLNERSLAFYATCDAPVDNAGFLYKKGGRHAAYHRRWFVLRGNMLFYFEDAASREPVGVIILEGCTVELVEAAEEFAFAVRFAGTRARTYVLAAESQDAMEGWVKALSRASFDYLRLVVRELEQQLAAVRGGGGMALPQPQPQSLPLPPSLPSALAPVPSLPSAPAPVPALPLPRRPSALPPKENGCAVWSTEATFRPGPEPPPPPPRRRASAPHGPLDMAPFARLHECYGQEIRALRGQWLSSRVQP
-
分子量
53.6 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
FAM109A, a member of the FAM109 protein family, has garnered interest in recent years due to its potential role in various cellular processes. Initially identified through a combination of genomic and transcriptomic approaches, FAM109A has been implicated in regulating key biological functions, including cell proliferation, differentiation, and apoptosis. Research indicates that FAM109A may play a significant role in cancer biology, particularly in modulating tumor growth and metastasis, making it a candidate for therapeutic targeting. Additionally, studies have shown that FAM109A interacts with essential signaling pathways, suggesting its involvement in the cellular response to stress and the maintenance of genomic stability. The production of recombinant FAM109A proteins has enabled researchers to delve deeper into its molecular mechanisms and functional properties, facilitating the exploration of its potential as a biomarker or a therapeutic target. The continued investigation of FAM109A is essential for understanding its precise role in health and disease, particularly in the context of malignancies where its dysregulation may contribute to tumorigenesis. This growing body of research underscores the importance of FAM109A in cellular regulation and its possible implications in clinical settings.
